| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2013PLoSO...869688T |
| P356 | DOI | 10.1371/JOURNAL.PONE.0069688 |
| P932 | PMC publication ID | 3716600 |
| P698 | PubMed publication ID | 23894523 |
| P5875 | ResearchGate publication ID | 253336621 |
| P50 | author | Rama P Kotipatruni | Q84742763 |
| P2093 | author name string | Dennis E Hallahan | |
| Daniel J Ferraro | |||
| Jerry J Jaboin | |||
| Dinesh Thotala | |||
| Jeffrey M Craft | |||
| Sandeep R Bhave | |||
| P2860 | cites work | The confluence-dependent interaction of cytosolic phospholipase A2-alpha with annexin A1 regulates endothelial cell prostaglandin E2 generation. | Q52852938 |
| Non-small cell lung cancer: prognostic factors in patients treated with surgery and postoperative radiation therapy | Q73225877 | ||
| Tumor response to radiotherapy regulated by endothelial cell apoptosis | Q73401346 | ||
| Radiosensitization with carboplatin for patients with unresectable stage III non-small-cell lung cancer: a phase III trial of the Cancer and Leukemia Group B and the Eastern Cooperative Oncology Group | Q78160747 | ||
| Cytosolic phospholipase A2 regulates viability of irradiated vascular endothelium | Q81486511 | ||
| cPLA2 is phosphorylated and activated by MAP kinase | Q24314148 | ||
| Modes of resistance to anti-angiogenic therapy | Q24608005 | ||
| Cancer statistics, 2013 | Q27860762 | ||
| Postoperative adjuvant therapy for patients with resected non-small cell lung cancer: still controversial after all these years | Q33897556 | ||
| Cytosolic Phospholipase A2 and Lysophospholipids in Tumor Angiogenesis | Q34145860 | ||
| Inhibitors of brain phospholipase A2 activity: their neuropharmacological effects and therapeutic importance for the treatment of neurologic disorders | Q34565668 | ||
| Phospholipase A(2) isoforms: a perspective | Q35125684 | ||
| Mechanism of radiation-induced bystander effects: a unifying model | Q35541188 | ||
| The Swedish Council on Technology Assessment in Health Care (SBU) Systematic Overview of Radiotherapy for Cancer including a Prospective Survey of Radiotherapy Practice in Sweden 2001--Summary and Conclusions | Q35574838 | ||
| Dual activity lysophosphatidic acid receptor pan-antagonist/autotaxin inhibitor reduces breast cancer cell migration in vitro and causes tumor regression in vivo | Q36246828 | ||
| Advances in radiation oncology. | Q36366796 | ||
| Roles of cPLA2alpha and arachidonic acid in cancer | Q36629023 | ||
| Radiation-induced cell signaling: inside-out and outside-in | Q36760964 | ||
| Anastellin, the angiostatic fibronectin peptide, is a selective inhibitor of lysophospholipid signaling | Q37135504 | ||
| Cancer-stimulated mesenchymal stem cells create a carcinoma stem cell niche via prostaglandin E2 signaling | Q37323724 | ||
| Cytosolic phospholipase A2 as a mediator of disease pathogenesis | Q37774040 | ||
| Targeted agents in non-small cell lung cancer (NSCLC): clinical developments and rationale for the combination with thoracic radiotherapy | Q37971168 | ||
| Combining angiogenesis inhibition and radiotherapy: a double-edged sword | Q38007807 | ||
| Transactivation of fetal liver kinase-1/kinase-insert domain-containing receptor by lysophosphatidylcholine induces vascular endothelial cell proliferation | Q40345232 | ||
| Cytosolic phospholipase A2: targeting cancer through the tumor vasculature | Q40689319 | ||
| Delayed oxidant-induced cell death involves activation of phospholipase A2. | Q40762207 | ||
| Induction of cPLA2 in lung epithelial cells and non-small cell lung cancer is mediated by Sp1 and c-Jun | Q40780263 | ||
| Induction of cytosolic phospholipase A2 by oncogenic Ras in human non-small cell lung cancer | Q41105606 | ||
| Activation of cytosolic phospholipase A2-{alpha} as a novel mechanism regulating endothelial cell cycle progression and angiogenesis | Q43177511 | ||
| Angiogenesis, microvascular architecture, microhemodynamics, and interstitial fluid pressure during early growth of human adenocarcinoma LS174T in SCID mice | Q43562373 | ||
| A new link in ovarian cancer angiogenesis: lysophosphatidic acid and vascular endothelial growth factor expression | Q43608436 | ||
| Differential role of cytosolic phospholipase A2 in the invasion of brain microvascular endothelial cells by Escherichia coli and Listeria monocytogenes | Q43716038 | ||
| Cytosolic phospholipase A2-alpha and cyclooxygenase-2 localize to intracellular membranes of EA.hy.926 endothelial cells that are distinct from the endoplasmic reticulum and the Golgi apparatus | Q45273421 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | e69688 | |
| P577 | publication date | 2013-07-19 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Cytosolic phospholipaseA2 inhibition with PLA-695 radiosensitizes tumors in lung cancer animal models | |
| P478 | volume | 8 |
| Q35948220 | Anti-vascular effects of the cytosolic phospholipase A2 inhibitor AVX235 in a patient-derived basal-like breast cancer model |
| Q38179801 | Chemical modulation of glycerolipid signaling and metabolic pathways |
| Q35886245 | Cytosolic phospholipase A₂: physiological function and role in disease |
| Q92642416 | Metabolomic Characterization of Human Model of Liver Rejection Identifies Aberrancies Linked to Cyclooxygenase (COX) and Nitric Oxide Synthase (NOS) |
| Q46681431 | Platelet Lipidomic Profiling: Novel Insight into Cytosolic Phospholipase A2α Activity and Its Role in Human Platelet Activation |
| Q40181455 | Sonic Hedgehog Activates Phospholipase A2 to Enhance Smoothened Ciliary Translocation |
| Q39627791 | The ATF6 pathway of the ER stress response contributes to enhanced viability in glioblastoma |
Search more.